Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.47 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 6/20 | 0.40 |
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | ESPL1 | Q14674 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | RECQL | P46063 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | TTR | P02766 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30616278 | 1.00 | TDP1 (0.48) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL28252592 | 0.87 | TDP1 (0.48) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL1505782 | 0.82 | TDP1 (0.45) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL11797728 | 0.82 | TDP1 (0.45) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL25352334 | 0.80 | GPR35 (0.52) | TDP1ALDH1A1HIF1AMAPTPKM | |
| SCHEMBL1193075 | 0.80 | ALDH1A1 (0.46) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL8654973 | 0.80 | ALDH1A1 (0.50) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL25354843 | 0.80 | GPR35 (0.47) | TDP1ATMALDH1A1HIF1AMAPT | |
| SCHEMBL8011720 | 0.80 | GPR35 (0.47) | TDP1ATMALDH1A1HIF1AMAPT | |
| SCHEMBL8112068 | 0.80 | TDP1 (0.44) | TDP1ATMALDH1A1HIF1AVCAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120058596-A | Novel synthesis method of key intermediate of cotinamide | 仁合益康集团有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-210813976-U | Distillation device for producing di-tetra-difluoronitrobenzene | 浙江嘉德精细化工有限公司 | 2020-06-23 | — | — | CN | claimed |
| US-8952083-B2 | Fluorocopolymer composition and its production process | ASAHI GLASS COMPANY, LIMITED (JP) | 2015-02-10 | — | — | US | claimed |
| US-20100204477-A1 | Methods and Processes For Syntheses and Manufacture of Antimicrobial 1(Ortho-Fluorophenyl)dihydropyridones | MICURX PHARMACEUTICALS, INC. (KY) | 2010-08-12 | — | — | US | claimed |
| WO-2010091272-A1 | METHODS AND PROCESSES FOR SYNTHESES AND MANUFACTURE OF ANTIMICROBIAL 1-(ORTHO-FLUOROPHENYL)DIHYDROPYRIDONES | MICURX PHARMACEUTICALS, INC. (US) | 2010-08-12 | — | — | WO | claimed |
| EP-0327504-B1 | N-BENZOYL-N'-TRIFLUOROPHENYLUREAS, THEIR PREPARATION AND USE FOR THE CONTROL OF PESTS | CIBA-GEIGY AG (CH) | 1993-05-12 | — | — | EP | claimed |
| JP-60222448-A | — | — | None | — | — | JP | disclosed |
| EP-4673141-A1 | NBD1 MODULATORS AND METHODS OF USING THE SAME | Sionna Therapeutics Inc. (US) | 2026-01-07 | — | — | EP | disclosed |
| US-20250368809-A1 | RESIN COMPOSITION | NAN YA PLASTICS CORPORATION (TW) | 2025-12-04 | — | — | US | disclosed |
| EP-4647127-A2 | COMPOUNDS FOR THE TREATMENT OF KINASE-DEPENDENT DISORDERS | Exelixis, Inc. (US) | 2025-11-12 | — | — | EP | disclosed |
| US-12398226-B2 | Resin composition | NAN YA PLASTICS CORPORATION (TW) | 2025-08-26 | — | — | US | disclosed |
| US-20250248975-A1 | MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | SCHRODINGER, LLC | 2025-08-07 | — | — | US | disclosed |
| EP-3743070-B1 | COMPOUNDS FOR THE TREATMENT OF KINASE-DEPENDENT DISORDERS | EXELIXIS INC (US) | 2025-07-23 | — | — | EP | disclosed |
| EP-0327504-A1 | N-Benzoyl-N'-trifluorophenylureas, their preparation and use for the control of pests | CIBA-GEIGY AG (CH) | 1989-08-09 | — | — | EP | disclosed |
| CN-1004272-B | PYRAZOLINE INSECTICIDES | FMC公司 | 1989-05-24 | — | — | CN | disclosed |
| EP-0275971-A1 | Process and intermediates for quinolonecaboxylic acid | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 1988-07-27 | — | — | EP | disclosed |
| US-4657913-A | Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents | WARNER-LAMBERT COMPANY (US) | 1987-04-14 | — | — | US | disclosed |
| EP-0202763-A1 | 5,6-Difluoronaphthyridines and 5,6,8-trifluoro-quinolines as antibacterial agents | WARNER-LAMBERT COMPANY (US) | 1986-11-26 | — | — | EP | disclosed |
| JP-S60222448-A | ANILINE COMPOUND AND ITS PRODUCTION | KYORIN PHARMACEUT CO LTD | 1985-11-07 | — | — | JP | disclosed |
| US-4370278-A | Nucleophilic substitution process | ETHYL CORPORATION (US) | 1983-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204477-A1 | Methods and Processes For Syntheses and Manufacture of Antimicrobial 1(Ortho-Fluorophenyl)dihydropyridones | DHPS, FDPS, CYP2F1 | TDP1 1658/4885ATM 4093/4885ALDH1A1 232/4885 |
| US-20250248975-A1 | MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | CFTR, ABCB1, PKD1 | TDP1 3209/4885ATM 1441/4885ALDH1A1 3545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.